Key Highlights

  • Nuix shares are changing hands at $1.82, down 0.82% on the day and down 23.53% over the past twelve months.
  • The investigative analytics provider has been expanding its Nuix Neo platform, which now underpins a growing share of its contracted revenue.
  • Recent results pointed to double-digit growth in annualised contract value alongside a swing back to statutory profitability.
  • A completed Acquisition and legal developments involving the company's directors have added further threads for the market to track.

Nuix Limited (ASX:NXL) is an Australian-founded investigative analytics and intelligence software provider whose tools are used by government, legal and corporate clients to search, analyse and make sense of large volumes of unstructured data. The company's flagship shift in recent years has centred on Nuix Neo, a newer generation platform aimed at replacing legacy products and expanding the recurring Revenue base. Nuix shares last traded at $1.82, down 0.82% on 11 Sep 2026, and the stock is down 23.53% over the past twelve months.

Nuix's Recent Results and Business Update

Nuix's results for the year to 30 June 2026 showed annualised contract value climbing to $260.0 million, with the Nuix Neo platform the standout contributor as its contract value nearly tripled to $78.5 million across 135 customers. Group revenue for the period came in at $263.2 million, an increase of close to 19% on the prior year, while adjusted management Earnings rose more sharply, lifting margins as the newer platform scaled.

The company also swung back to a statutory net profit for the year, a marked turnaround from the loss it posted twelve months earlier, and reported a substantial improvement in underlying cash generation that helped lift its net cash position.

During the period, Nuix completed the acquisition of data-visualisation business Linkurious, restructured its go-to-market operations into two regional sales teams, and appointed a new Chief Customer Officer as part of a broader reorganisation of its product and technology functions.

On the legal front, the Federal Court dismissed claims brought by the corporate regulator against the company and a group of former directors, though an appeal covering the company itself remains before the courts, while the outcome for the individual directors has been finalised.

Catalysts to Watch

  • Continued adoption and cross-sell of the Nuix Neo platform, including further gains in its share of total contract value.
  • Progress integrating the recently acquired Linkurious business and any early evidence of cross-sell traction.
  • Delivery against forward guidance for contract value and earnings, including the planned step-up in Research and Development spending.
  • Developments in the ongoing regulatory appeal process involving the company.

Risks to Monitor

  • Slower-than-expected migration of customers onto the Nuix Neo platform could weigh on contract value growth.
  • A one-off increase in planned research and development spending is expected to limit earnings growth in the near term.
  • Currency movements, given the business generates meaningful revenue outside Australia.
  • Uncertainty tied to the ongoing regulatory appeal process.

Conclusion

Nuix shares have fallen over the past year even as the underlying business has reported growth in contract value, revenue and a return to statutory profit. Whether the stock earns a place on an investor's watchlist may come down to how quickly the Nuix Neo transition continues to scale, how the Linkurious integration progresses, and how the remaining legal proceedings play out.